EASL_2024-GLP1_FINAL
Loading viewer...
report
Format: PDF report
This report presents the findings of the ENLIVEN trial, evaluating the efficacy and safety of Pegozafermin in NASH patients with F2/F3 fibrosis when combined with GLP-1 therapy.
Loading viewer...
report
Format: PDF report
This report presents the findings of the ENLIVEN trial, evaluating the efficacy and safety of Pegozafermin in NASH patients with F2/F3 fibrosis when combined with GLP-1 therapy.
report
report
Flagstar Bank
report
Lorillard
report
Investec
report
Smith & Wesson
